Erlotinib Is Being Studied With Or Without An Investigational Drug, PF-02341066, In Patients With Lung Cancer
Clinical trial NCT00965731 · COMPLETED
Trial details
- NCT number
- NCT00965731
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2011-12-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.